Literature DB >> 8957202

The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats.

A Holmäng1, N Yoshida, E Jennische, A Waldenström, P Björntorp.   

Abstract

Left ventricular hypertrophy is a condition with high mortality. An association with insulin resistance and hyperinsulinaemia has recently been suggested. The aim of this study was to examine the effects of isolated hyperinsulinaemia on cardiac weight and haemodynamic regulation. Rats were exposed to hyperinsulinaemia for 7 weeks after adrenalectomy with corticosterone substitution and continuous infusion of propranolol to control counter-regulatory mechanism (n = 15) (AIP group). Hypoglycaemia was prevented by glucose in the drinking water. Hyperinsulinaemic (AIP) rats were heavier and had increased relative masses of the myocardium (left ventricle 17% and right ventricle 20%), kidneys and adipose tissues in comparison with normoinsulinaemic adrenalectomized, corticosterone- and propranolol-treated controls (AP) (n = 10). Blood pressure in the insulin-exposed animals, measured weekly by the tail-cuff method in conscious rats, was not different from (AP) controls over 5 weeks, but increased in the sixth week. At the end of the seventh experimental week, blood pressure measured intra-arterially was also found to be elevated. Heart rate was not changed but total peripheral resistance was about twice that of controls (P < 0.001). Cardiac output and stroke volume was 30-40% lower in the AIP rats (P < 0.05). It is concluded that exposure to elevated insulin levels with control of counter-regulating mechanisms from beta-adrenergic mechanisms and adrenals is not immediately followed by blood pressure elevation. It is, therefore, suggested that early onset of blood pressure elevation after insulin exposure might be caused by insulin counter-regulatory events, causing both insulin resistance and blood pressure elevation. The long-term adaptations may involve a direct influence by insulin as a 'trophic factor' on myocardial and on peripheral resistance levels, followed by increased blood pressure, decreased cardiac and stroke volume.

Entities:  

Mesh:

Year:  1996        PMID: 8957202     DOI: 10.1046/j.1365-2362.1996.2880577.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

Review 1.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Ambulatory blood pressure monitoring and cardiac hypertrophy in children with metabolic syndrome.

Authors:  Berna Kamaci Bostanci; Mahmut Civilibal; Murat Elevli; Nilgun Selcuk Duru
Journal:  Pediatr Nephrol       Date:  2012-05-19       Impact factor: 3.714

3.  Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Chaoyang Li; Earl S Ford; Lisa C McGuire; Ali H Mokdad
Journal:  J Epidemiol Community Health       Date:  2007-01       Impact factor: 3.710

4.  Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael L Chuang; Carol J Salton; Caroline S Fox; Susan J Blease; Susan B Yeon; Warren J Manning; Christopher J O'Donnell
Journal:  Circ Cardiovasc Imaging       Date:  2010-03-05       Impact factor: 7.792

5.  Metabolic syndrome and risk for heart failure in middle-aged men.

Authors:  E Ingelsson; J Arnlöv; L Lind; J Sundström
Journal:  Heart       Date:  2006-05-22       Impact factor: 5.994

6.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.

Authors:  E D Abel; H C Kaulbach; R Tian; J C Hopkins; J Duffy; T Doetschman; T Minnemann; M E Boers; E Hadro; C Oberste-Berghaus; W Quist; B B Lowell; J S Ingwall; B B Kahn
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

7.  Association of glucose metabolism with diastolic function along the diabetic continuum.

Authors:  R Stahrenberg; F Edelmann; M Mende; A Kockskämper; H D Düngen; M Scherer; M M Kochen; L Binder; C Herrmann-Lingen; L Schönbrunn; G Gelbrich; G Hasenfuss; B Pieske; R Wachter
Journal:  Diabetologia       Date:  2010-04-13       Impact factor: 10.122

8.  Development of metabolic syndrome and electrocardiographic features of left ventricular hypertrophy in middle-aged working subjects.

Authors:  M Rigato; F Boscari; G Marcuzzo; S Vigili de Kreutzenberg; M C Marescotti; A Avogaro; G P Fadini
Journal:  J Endocrinol Invest       Date:  2013-07-15       Impact factor: 4.256

9.  Heart failure in acute ischemic stroke.

Authors:  Elisa Cuadrado-Godia; Angel Ois; Jaume Roquer
Journal:  Curr Cardiol Rev       Date:  2010-08

10.  The relationship between metabolic syndrome and left ventricular mass index in obese children.

Authors:  Mehmet Emre Atabek; Esra Akyüz; Beray Selver Eklioğlu; Derya Çimen
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.